Cite
HARVARD Citation
Salcedo, J. et al. (2019). Cost-effectiveness of rivaroxaban versus warfarin for treatment of nonvalvular atrial fibrillation in patients with worsening renal function. International journal of cardiology. pp. 53-58. [Online].